OverviewSuggest Edit

Karuna Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapies to address disabling neuropsychiatric conditions. The company lead product, KarXT, is an oral modulator of muscarinic receptors. It specializes in research, development, commercialization of numerous central neural system agents and products targeted at a broad range of psychiatric and neurological conditions.

TypePublic
Founded2009
HQBoston, US
Websitekarunatx.com

Locations

Karuna Therapeutics is headquartered in
Boston, United States

Location Map

Latest Updates

Employees (est.) (Jul 2019)16
Share Price (Oct 2019)$13.4 (+18%)

Key People/Management at Karuna Therapeutics

Steve Paul

Steve Paul

Chairman of the Board, President and Chief Executive Officer
Stephen Brannan

Stephen Brannan

Chief Medical Officer
Andrew Miller

Andrew Miller

Founder and Chief Operating Officer
Troy A. Ignelzi

Troy A. Ignelzi

CFO
Giorgio Attardo

Giorgio Attardo

Vice President, CMC and Preclinical Development
Gregory T. Brophy

Gregory T. Brophy

Head of Regulatory (Consultant)
Show more

Karuna Therapeutics Office Locations

Karuna Therapeutics has an office in Boston
Boston, US (HQ)
33 Arch Street
Show all (1)

Karuna Therapeutics Financials and Metrics

Karuna Therapeutics Revenue

USD

EBIT (Q2, 2019)

(15.1m)

Market capitalization (16-Oct-2019)

313.5m

Closing stock price (16-Oct-2019)

13.4

Cash (30-Jun-2019)

10.5m
Karuna Therapeutics's current market capitalization is $313.5 m.
USDFY, 2017FY, 2018

General and administrative expense

1.2m3.0m

R&D expense

3.6m11.5m

Operating expense total

4.8m14.5m

EBIT

(4.8m)(14.5m)
Annual
USDFY, 2017FY, 2018

Cash

1.9m8.9m

Prepaid Expenses

175.0k1.7m

Current Assets

2.1m15.6m

PP&E

12.0k138.0k
Quarterly
USDQ2, 2019

Cash

10.5m

Current Assets

79.0m

PP&E

186.0k

Total Assets

79.4m
Annual
USDFY, 2017FY, 2018

Net Income

(6.0m)(17.5m)

Depreciation and Amortization

1.0k6.0k

Accounts Payable

537.0k(529.0k)

Cash From Operating Activities

(4.0m)(15.4m)
Quarterly
USDQ2, 2019

Net Income

(27.1m)

Depreciation and Amortization

22.0k

Accounts Payable

253.0k

Cash From Operating Activities

(15.7m)
USDY, 2019

Financial Leverage

-1.7 x
Show all financial metrics

Karuna Therapeutics Online and Social Media Presence

Embed Graph

Karuna Therapeutics Frequently Asked Questions

  • When was Karuna Therapeutics founded?

    Karuna Therapeutics was founded in 2009.

  • Who are Karuna Therapeutics key executives?

    Karuna Therapeutics's key executives are Steve Paul, Stephen Brannan and Andrew Miller.

  • How many employees does Karuna Therapeutics have?

    Karuna Therapeutics has 16 employees.

  • Who are Karuna Therapeutics competitors?

    Competitors of Karuna Therapeutics include Jour, Nori Health and One Medical Group.

  • Where is Karuna Therapeutics headquarters?

    Karuna Therapeutics headquarters is located at 33 Arch Street, Boston.

  • Where are Karuna Therapeutics offices?

    Karuna Therapeutics has an office in Boston.

  • How many offices does Karuna Therapeutics have?

    Karuna Therapeutics has 1 office.